+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glycopyrronium"

Bronchodilators Market Report 2025 - Product Thumbnail Image

Bronchodilators Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Lower Respiratory Tract Therapeutics Market Report 2025 - Product Thumbnail Image

Lower Respiratory Tract Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pulmonary Drug Delivery Systems Market - Product Thumbnail Image

Pulmonary Drug Delivery Systems Market

  • Report
  • September 2025
  • 150 Pages
  • Global
From
From
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Glycopyrronium is a medication used to treat chronic obstructive pulmonary disease (COPD). It is a long-acting anticholinergic bronchodilator, which works by relaxing the muscles in the airways, allowing air to flow more freely. It is typically used in combination with other medications to treat COPD, such as inhaled corticosteroids and long-acting beta-agonists. Glycopyrronium is available in both oral and inhalation forms, and is typically prescribed for long-term use. Glycopyrronium is a relatively new medication, and is not yet widely used in the treatment of COPD. However, it is becoming increasingly popular due to its effectiveness and long-term safety profile. It is also relatively inexpensive compared to other COPD medications, making it an attractive option for many patients. Some of the companies in the Glycopyrronium market include GlaxoSmithKline, Boehringer Ingelheim, and Mylan. Show Less Read more